{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:33:41Z","timestamp":1789450421409,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T00:00:00Z","timestamp":1548460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","award":["GIA 1704"],"award-info":[{"award-number":["GIA 1704"]}],"id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12035-019-1485-6","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T14:02:27Z","timestamp":1548511347000},"page":"5844-5855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"56","author":[{"given":"Tesfaye Wolde","family":"Tefera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley S.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-0770","authenticated-orcid":false,"given":"Karin","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,26]]},"reference":[{"issue":"9769","key":"1485_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942\u2013955. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)61156-7","journal-title":"Lancet"},{"key":"1485_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-8-28","volume":"8","author":"S Chen","year":"2013","unstructured":"Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8:28. \n                    https:\/\/doi.org\/10.1186\/1750-1326-8-28","journal-title":"Mol Neurodegener"},{"issue":"5870","key":"1485_CR3","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319(5870):1668\u20131672. \n                    https:\/\/doi.org\/10.1126\/science.1154584","journal-title":"Science"},{"issue":"22","key":"1485_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","volume":"326","author":"JD Rothstein","year":"1992","unstructured":"Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326(22):1464\u20131468. \n                    https:\/\/doi.org\/10.1056\/NEJM199205283262204","journal-title":"N Engl J Med"},{"key":"1485_CR5","first-page":"7","volume":"68","author":"JD Rothstein","year":"1995","unstructured":"Rothstein JD (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 68:7\u201320 discussion 21-27","journal-title":"Adv Neurol"},{"issue":"4","key":"1485_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.410380424","volume":"38","author":"PJ Shaw","year":"1995","unstructured":"Shaw PJ, Ince PG, Falkous G, Mantle D (1995) Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 38(4):691\u2013695. \n                    https:\/\/doi.org\/10.1002\/ana.410380424","journal-title":"Ann Neurol"},{"issue":"30","key":"1485_CR7","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101(30):11159\u201311164. \n                    https:\/\/doi.org\/10.1073\/pnas.0402026101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1485_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis L, Pradat PF, Ludolph AC, Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10(1):75\u201382. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70224-6","journal-title":"Lancet Neurol"},{"key":"1485_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2377-13-84","volume":"13","author":"S Korner","year":"2013","unstructured":"Korner S, Hendricks M, Kollewe K, Zapf A, Dengler R, Silani V, Petri S (2013) Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurol 13:84. \n                    https:\/\/doi.org\/10.1186\/1471-2377-13-84","journal-title":"BMC Neurol"},{"issue":"3","key":"1485_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"JC Desport","year":"2001","unstructured":"Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74(3):328\u2013334","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1485_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.nbd.2006.01.001","volume":"22","author":"SE Browne","year":"2006","unstructured":"Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, Beal MF (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22(3):599\u2013610. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.01.001","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1485_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/jcbfm.2011.155","volume":"32","author":"K Miyazaki","year":"2012","unstructured":"Miyazaki K, Masamoto K, Morimoto N, Kurata T, Mimoto T, Obata T, Kanno I, Abe K (2012) Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb Blood Flow Metab 32(3):456\u2013467. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2011.155","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"1485_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.410220504","volume":"22","author":"MC Dalakas","year":"1987","unstructured":"Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G (1987) Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol 22(5):580\u2013586. \n                    https:\/\/doi.org\/10.1002\/ana.410220504","journal-title":"Ann Neurol"},{"key":"1485_CR14","doi-asserted-by":"publisher","unstructured":"Tefera TW, Borges K (2018) Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab:271678X18764775. \n                    https:\/\/doi.org\/10.1177\/0271678X18764775","DOI":"10.1177\/0271678X18764775"},{"issue":"11\u201312","key":"1485_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","volume":"1762","author":"SC Barber","year":"2006","unstructured":"Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762(11\u201312):1051\u20131067. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2006.03.008","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1485_CR16","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","volume":"53","author":"E Niedzielska","year":"2016","unstructured":"Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53(6):4094\u20134125. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9337-5","journal-title":"Mol Neurobiol"},{"key":"1485_CR17","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1007\/s12035-015-9567-6","volume":"53","author":"C Veyrat-Durebex","year":"2015","unstructured":"Veyrat-Durebex C, Corcia P, Piver E, Devos D, Dangoumau A, Gouel F, Vourc'h P, Emond P et al (2015) Disruption of TCA cycle and glutamate metabolism identified by metabolomics in an in vitro model of amyotrophic lateral sclerosis. Mol Neurobiol 53:6910\u20136924. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9567-6","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1485_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12031-010-9332-2","volume":"41","author":"A D'Arrigo","year":"2010","unstructured":"D'Arrigo A, Colavito D, Pena-Altamira E, Fabris M, Dam M, Contestabile A, Leon A (2010) Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease? J Mol Neurosci 41(3):404\u2013415. \n                    https:\/\/doi.org\/10.1007\/s12031-010-9332-2","journal-title":"J Mol Neurosci"},{"issue":"Pt 9","key":"1485_CR19","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1093\/brain\/awr193","volume":"134","author":"L Ferraiuolo","year":"2011","unstructured":"Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, Kirby J, Shaw PJ (2011) Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134(Pt 9):2627\u20132641. \n                    https:\/\/doi.org\/10.1093\/brain\/awr193","journal-title":"Brain"},{"key":"1485_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fnins.2016.00611","volume":"10","author":"TW Tefera","year":"2016","unstructured":"Tefera TW, Borges K (2016) Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci 10:611. \n                    https:\/\/doi.org\/10.3389\/fnins.2016.00611","journal-title":"Front Neurosci"},{"key":"1485_CR21","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s11064-016-2106-7","volume":"42","author":"TW Tefera","year":"2016","unstructured":"Tefera TW, Tan KN, McDonald TS, Borges K (2016) Alternative fuels in epilepsy and amyotrophic lateral sclerosis. Neurochem Res 42:1610\u20131620. \n                    https:\/\/doi.org\/10.1007\/s11064-016-2106-7","journal-title":"Neurochem Res"},{"issue":"1","key":"1485_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/nbm.740","volume":"15","author":"JE Belle Le","year":"2002","unstructured":"Le Belle JE, Harris NG, Williams SR, Bhakoo KK (2002) A comparison of cell and tissue extraction techniques using high-resolution 1H-NMR spectroscopy. NMR Biomed 15(1):37\u201344","journal-title":"NMR Biomed"},{"issue":"1","key":"1485_CR23","doi-asserted-by":"publisher","first-page":"ENEURO.0341","DOI":"10.1523\/ENEURO.0341-16.2017","volume":"4","author":"TS McDonald","year":"2017","unstructured":"McDonald TS, Carrasco-Pozo C, Hodson MP, Borges K (2017) Alterations in cytosolic and mitochondrial [U-13C]glucose metabolism in a chronic epilepsy mouse model. eNeuro 4(1):ENEURO.0341\u2013ENEU16.2017. \n                    https:\/\/doi.org\/10.1523\/ENEURO.0341-16.2017","journal-title":"eNeuro"},{"issue":"2","key":"1485_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tvjl.2015.07.031","volume":"206","author":"CE Medina-Torres","year":"2015","unstructured":"Medina-Torres CE, van Eps AW, Nielsen LK, Hodson MP (2015) A liquid chromatography-tandem mass spectrometry-based investigation of the lamellar interstitial metabolome in healthy horses and during experimental laminitis induction. Vet J 206(2):161\u2013169. \n                    https:\/\/doi.org\/10.1016\/j.tvjl.2015.07.031","journal-title":"Vet J"},{"issue":"4","key":"1485_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/jnc.14275","volume":"144","author":"KN Tan","year":"2018","unstructured":"Tan KN, Simmons D, Carrasco-Pozo C, Borges K (2018) Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration. J Neurochem 144(4):431\u2013442. \n                    https:\/\/doi.org\/10.1111\/jnc.14275","journal-title":"J Neurochem"},{"issue":"Pt 7","key":"1485_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/brain\/awh503","volume":"128","author":"J Kirby","year":"2005","unstructured":"Kirby J, Halligan E, Baptista MJ, Allen S, Heath PR, Holden H, Barber SC, Loynes CA et al (2005) Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain 128(Pt 7):1686\u20131706. \n                    https:\/\/doi.org\/10.1093\/brain\/awh503","journal-title":"Brain"},{"issue":"6","key":"1485_CR27","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/j.1471-4159.1993.tb07478.x","volume":"61","author":"AC Bowling","year":"1993","unstructured":"Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61(6):2322\u20132325","journal-title":"J Neurochem"},{"issue":"3","key":"1485_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/17482960801933942","volume":"9","author":"H Mitsumoto","year":"2008","unstructured":"Mitsumoto H, Santella RM, Liu X, Bogdanov M, Zipprich J, Wu HC, Mahata J, Kilty M et al (2008) Oxidative stress biomarkers in sporadic ALS. Amyotroph Lateral Scler 9(3):177\u2013183. \n                    https:\/\/doi.org\/10.1080\/17482960801933942","journal-title":"Amyotroph Lateral Scler"},{"issue":"10","key":"1485_CR29","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","volume":"62","author":"EP Simpson","year":"2004","unstructured":"Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH (2004) Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62(10):1758\u20131765","journal-title":"Neurology"},{"issue":"8","key":"1485_CR30","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1074\/jbc.M209915200","volume":"278","author":"S Allen","year":"2003","unstructured":"Allen S, Heath PR, Kirby J, Wharton SB, Cookson MR, Menzies FM, Banks RE, Shaw PJ (2003) Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J Biol Chem 278(8):6371\u20136383. \n                    https:\/\/doi.org\/10.1074\/jbc.M209915200","journal-title":"J Biol Chem"},{"key":"1485_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuint.2017.08.009","volume":"112","author":"T Chen","year":"2017","unstructured":"Chen T, Turner BJ, Beart PM, Sheehan-Hennessy L, Elekwachi C, Muyderman H (2017) Glutathione monoethyl ester prevents TDP-43 pathology in motor neuronal NSC-34 cells. Neurochem Int 112:278\u2013287. \n                    https:\/\/doi.org\/10.1016\/j.neuint.2017.08.009","journal-title":"Neurochem Int"},{"issue":"3","key":"1485_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neuroscience.2006.09.064","volume":"144","author":"L Chi","year":"2007","unstructured":"Chi L, Ke Y, Luo C, Gozal D, Liu R (2007) Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144(3):991\u20131003. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2006.09.064","journal-title":"Neuroscience"},{"issue":"3","key":"1485_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbd.2011.04.025","volume":"43","author":"MR Vargas","year":"2011","unstructured":"Vargas MR, Johnson DA, Johnson JA (2011) Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model. Neurobiol Dis 43(3):543\u2013551. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.04.025","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1485_CR34","doi-asserted-by":"publisher","first-page":"AN20130046","DOI":"10.1042\/AN20130046","volume":"6","author":"LD Santa-Cruz","year":"2014","unstructured":"Santa-Cruz LD, Tapia R (2014) Role of energy metabolic deficits and oxidative stress in excitotoxic spinal motor neuron degeneration in vivo. ASN Neuro 6(2):AN20130046. \n                    https:\/\/doi.org\/10.1042\/AN20130046","journal-title":"ASN Neuro"},{"issue":"4","key":"1485_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/17482960600947689","volume":"7","author":"XS Wang","year":"2006","unstructured":"Wang XS, Simmons Z, Liu W, Boyer PJ, Connor JR (2006) Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph Lateral Scler 7(4):201\u2013210. \n                    https:\/\/doi.org\/10.1080\/17482960600947689","journal-title":"Amyotroph Lateral Scler"},{"issue":"6","key":"1485_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ncb1881","volume":"11","author":"A Herrero-Mendez","year":"2009","unstructured":"Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, Bolanos JP (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C-Cdh1. Nat Cell Biol 11(6):747\u2013752. \n                    https:\/\/doi.org\/10.1038\/ncb1881","journal-title":"Nat Cell Biol"},{"key":"1485_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/B978-0-12-397179-1.00003-8","volume-title":"From molecules to networks","author":"GA Dienel","year":"2014","unstructured":"Dienel GA (2014) Chapter 3 - energy metabolism in the brain. In: From molecules to networks, 3rd edn. Academic, Boston, pp. 53\u2013117. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-397179-1.00003-8","edition":"3"},{"issue":"2","key":"1485_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nbd.2011.04.003","volume":"43","author":"G D'Alessandro","year":"2011","unstructured":"D'Alessandro G, Calcagno E, Tartari S, Rizzardini M, Invernizzi RW, Cantoni L (2011) Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism. Neurobiol Dis 43(2):346\u2013355. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.04.003","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"1485_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0022-510X(01)00620-7","volume":"191","author":"G Siciliano","year":"2001","unstructured":"Siciliano G, Pastorini E, Pasquali L, Manca ML, Iudice A, Murri L (2001) Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci 191(1\u20132):61\u201365","journal-title":"J Neurol Sci"},{"issue":"2","key":"1485_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/146608202760196011","volume":"3","author":"G Siciliano","year":"2002","unstructured":"Siciliano G, D'Avino C, Del Corona A, Barsacchi R, Kusmic C, Rocchi A, Pastorini E, Murri L (2002) Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 3(2):57\u201362. \n                    https:\/\/doi.org\/10.1080\/146608202760196011","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"26","key":"1485_CR41","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1073\/pnas.1308421110","volume":"110","author":"JC Dodge","year":"2013","unstructured":"Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, Searles M, Taksir TV, Misra K et al (2013) Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci U S A 110(26):10812\u201310817. \n                    https:\/\/doi.org\/10.1073\/pnas.1308421110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"1485_CR42","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1523\/JNEUROSCI.20-24-08972.2000","volume":"20","author":"L Tretter","year":"2000","unstructured":"Tretter L, Adam-Vizi V (2000) Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 20(24):8972\u20138979","journal-title":"J Neurosci"},{"issue":"8","key":"1485_CR43","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1371\/journal.pone.0000690","volume":"2","author":"RJ Mailloux","year":"2007","unstructured":"Mailloux RJ, Beriault R, Lemire J, Singh R, Chenier DR, Hamel RD, Appanna VD (2007) The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One 2(8):e690. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0000690","journal-title":"PLoS One"},{"issue":"8","key":"1485_CR44","doi-asserted-by":"publisher","first-page":"e0161816","DOI":"10.1371\/journal.pone.0161816","volume":"11","author":"TW Tefera","year":"2016","unstructured":"Tefera TW, Wong Y, Barkl-Luke ME, Ngo ST, Thomas NK, McDonald TS, Borges K (2016) Triheptanoin protects motor neurons and delays the onset of motor symptoms in a mouse model of amyotrophic lateral sclerosis. PLoS One 11(8):e0161816. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0161816","journal-title":"PLoS One"},{"issue":"7","key":"1485_CR45","doi-asserted-by":"publisher","first-page":"e103526","DOI":"10.1371\/journal.pone.0103526","volume":"9","author":"C Ari","year":"2014","unstructured":"Ari C, Poff AM, Held HE, Landon CS, Goldhagen CR, Mavromates N, D'Agostino DP (2014) Metabolic therapy with Deanna protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS One 9(7):e103526. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0103526","journal-title":"PLoS One"},{"key":"1485_CR46","doi-asserted-by":"crossref","unstructured":"Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A 95 (15):8892\u20138897","DOI":"10.1073\/pnas.95.15.8892"},{"key":"1485_CR47","doi-asserted-by":"publisher","unstructured":"Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Leon A, Robinson KM, Mason RP, Beckman JS, Barbeito L, Radi R (2008) Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci 28(16):4115\u20134122. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5308-07.2008","DOI":"10.1523\/JNEUROSCI.5308-07.2008"},{"key":"1485_CR48","doi-asserted-by":"publisher","unstructured":"Miquel E, Cassina A, Martinez-Palma L, Souza JM, Bolatto C, Rodriguez-Bottero S, Logan A, Smith RA, Murphy MP, Barbeito L, Radi R, Cassina P (2014) Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radic Biol Med 70:204\u2013213. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.02.019","DOI":"10.1016\/j.freeradbiomed.2014.02.019"},{"issue":"11","key":"1485_CR49","doi-asserted-by":"publisher","first-page":"e49191","DOI":"10.1371\/journal.pone.0049191","volume":"7","author":"W Zhao","year":"2012","unstructured":"Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, Lange D, Bilski A et al (2012) Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS One 7(11):e49191. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0049191","journal-title":"PLoS One"},{"issue":"29","key":"1485_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2202-7-29","volume":"7","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M et al (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7(29):29. \n                    https:\/\/doi.org\/10.1186\/1471-2202-7-29","journal-title":"BMC Neurosci"},{"issue":"7676","key":"1485_CR51","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1038\/550S120a","volume":"550","author":"A Scott","year":"2017","unstructured":"Scott A (2017) Drug therapy: on the treatment trail for ALS. Nature 550(7676):S120\u2013S121. \n                    https:\/\/doi.org\/10.1038\/550S120a","journal-title":"Nature"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1485-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T19:05:07Z","timestamp":1579979107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1485-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,26]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1485-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,26]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the University of Queensland Animal Ethics Committee (SBMS 128\/14) and followed the guidelines of the Queensland Animal Care and Protection Act 2001.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}